TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3593897

Group type: EXPERIMENTAL
Intervention: Sucralfate (2 g) before ketoprofen (50 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ketoprofen (50 mg) alone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sucralfate (2 g) before indomethacin (50 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Indomethacin (50 mg) alone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sucralfate (2 g) before naproxen (500 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Naproxen (500 mg) alone
Number of subjects: 6
Study: 28476259

Group type: EXPERIMENTAL
Intervention: Prednisone (40 mg orally for 4 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27384560

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 0
Study: 24635755

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR) 0.5 mg
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR) 0.5 mg + intravitreal triamcinolone acetonide (IVTA) 1 mg
Number of subjects: 57
Study: 22086153

Group type: EXPERIMENTAL
Intervention: Pictures method
Number of subjects: 16

Group type: COMPARATOR
Intervention: Visual analogue scales (VAS)
Number of subjects: 16
Study: 20079897

Group type: EXPERIMENTAL
Intervention: CO2 as the distension medium
Number of subjects: 264

Group type: COMPARATOR
Intervention: Normal saline as the distension medium
Number of subjects: 264
Study: 18248809

Group type: EXPERIMENTAL
Intervention: HPV screening
Number of subjects: 61149

Group type: COMPARATOR
Intervention: Cytological screening
Number of subjects: 61149

Group type: EXPERIMENTAL
Intervention: HPV screening with cytology triage
Number of subjects: 61149
Study: 16548351

Group type: EXPERIMENTAL
Intervention: Jieguxujin granule (JGXJG)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Sanqi tablet (SQT)
Number of subjects: 400
Study: 12517464

Group type: EXPERIMENTAL
Intervention: Antidepressant (fluoxetine)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Psychological treatment
Number of subjects: 450
Study: 10080414

Group type: EXPERIMENTAL
Intervention: hyperkinetic-WMI
Number of subjects: 6232

Group type: EXPERIMENTAL
Intervention: nonhyperkinetic-WMI
Number of subjects: 6232

Group type: EXPERIMENTAL
Intervention: hyperkinetic-WMI (as an independent variable)
Number of subjects: 6232
Study: 7717553

Group type: EXPERIMENTAL
Intervention: FIO2 = 0.4 (group 1, n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: FIO2 = 1.0 (group 2, n = 6)
Number of subjects: 12
Study: 2127261

Group type: EXPERIMENTAL
Intervention: azidothymidine (AZT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 7259216

Group type: EXPERIMENTAL
Intervention: Dinitrochlorobenzene (DNCB)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Croton oil
Number of subjects: 22
Study: 29659187

Group type: EXPERIMENTAL
Intervention: Test formulation of anastrozole 1.0-mg tablet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference formulation of anastrozole (Arimidex 1.0-mg tablet)
Number of subjects: 20
Study: 29931719

Group type: COMPARATOR
Intervention: High fat + protein (HFHP) meal
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Standard meal (carbohydrate-only)
Number of subjects: 15
Study: 27411081

Group type: COMPARATOR
Intervention: Back position for catheter insertion
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Right side position for catheter insertion
Number of subjects: 88
Study: 25458048

Group type: EXPERIMENTAL
Intervention: Parecoxib 0.5 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Morphine 50 μg/kg
Number of subjects: 50
Study: 22551976

Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists (VKA) treatment
Number of subjects: 176

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 176
Study: 20127656

Group type: EXPERIMENTAL
Intervention: Continuous blood purification (CBP) for 24 hours
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Continuous blood purification (CBP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Patients with MODS (compared to normal controls)
Number of subjects: 22
Study: 18242994

Group type: EXPERIMENTAL
Intervention: Tegasorb
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tegaderm
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 15699689

Group type: EXPERIMENTAL
Intervention: Fructo-oligosaccharide formula (1.5 g/L)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fructo-oligosaccharide formula (3.0 g/L)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (human milk)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (unsupplemented formula)
Number of subjects: 72
Study: 11914742

Group type: EXPERIMENTAL
Intervention: Diet rich in polyunsaturated fatty acids
Number of subjects: 17

Group type: COMPARATOR
Intervention: Diet rich in saturated fatty acids
Number of subjects: 17
Study: 10446816

Group type: EXPERIMENTAL
Intervention: Acetazolamide 250 mg every 6 hrs for a total of four doses
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acetazolamide 500 mg as a single dose
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study: 7844602

Group type: EXPERIMENTAL
Intervention: Adoptive immunotherapy with tumor-infiltrating lymphocytes (TIL) genetically modified with a retroviral vector containing the NeoR gene.
Number of subjects: 5
Study: 2085872

Group type: EXPERIMENTAL
Intervention: Nitrate therapy (2 x 20 mg IS‐5‐MN and 1 x 120 mg ISDN sustained release)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 454092

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tranylcypromine
Number of subjects: 0

Group type: COMPARATOR
Intervention: MAO inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tricyclic antidepressants (TCAs)
Number of subjects: 0
Study: 7082211

Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30016404

Group type: EXPERIMENTAL
Intervention: Ultracision Harmonic Scalpel
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PEAK-Plasmablade
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: All methods evaluated
Number of subjects: 57
Study: 30061523

Group type: EXPERIMENTAL
Intervention: T1 (full DMLS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: T2 (machined upper and DMLS lower)
Number of subjects: 50

Group type: COMPARATOR
Intervention: T3 (DMLS upper and machined lower)
Number of subjects: 50

Group type: COMPARATOR
Intervention: T4 (full machined)
Number of subjects: 50
Study: 27568389

Group type: EXPERIMENTAL
Intervention: Deep pressure input during wisdom tooth extraction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no deep pressure input)
Number of subjects: 0
Study: 24967760

Group type: EXPERIMENTAL
Intervention: Protocol-driven teaching program
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-protocol driven teaching program
Number of subjects: 18
Study: 22525398

Group type: EXPERIMENTAL
Intervention: Ribosome-component immune modulator (RCIM)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 20494239

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (improvement in diet, increase in physical activity, reduction in cigarette smoking through educational interviews, lectures, and publications)
Number of subjects: 1754

Group type: COMPARATOR
Intervention: Control group (no lifestyle intervention)
Number of subjects: 1754

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 1754

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1754
Study: 18043056

Group type: EXPERIMENTAL
Intervention: Macintosh blade
Number of subjects: 11

Group type: COMPARATOR
Intervention: Miller blade
Number of subjects: 11
Study: 16096858

Group type: EXPERIMENTAL
Intervention: Azithromycin (AZM) 250 mg twice a week for 12 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12399139

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zuclopenthixol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 9951979

Group type: EXPERIMENTAL
Intervention: SB MMR vaccine (Priorix; SmithKline Beecham Biologicals)
Number of subjects: 4702

Group type: COMPARATOR
Intervention: Merck MMR vaccine (M‐M‐R II; Merck & Co. Inc)
Number of subjects: 4702
Study: 7495925

Group type: EXPERIMENTAL
Intervention: pindolol pretreatment
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: MK-212
Number of subjects: 11
Study: 2178931

Group type: COMPARATOR
Intervention: Simvastatin alone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Simvastatin in association with cholestyramine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 66
Study: 35208

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg three times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clobazam (investigational 1,5-benzodiazepine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29317191

Group type: EXPERIMENTAL
Intervention: Ramucirumab 10 mg/kg every 2 weeks with erlotinib 150 mg/d
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 28557758

Group type: EXPERIMENTAL
Intervention: Repeat antenatal betamethasone
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo (single course)
Number of subjects: 185
Study: 25679172

Group type: EXPERIMENTAL
Intervention: Intermediate dose calculation during optimization
Number of subjects: 11
Study: 22975755

Group type: COMPARATOR
Intervention: Golimumab treatment
Number of subjects: 100
Study: 22216750

Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18212177

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) treatment
Number of subjects: 43
Study: 16357874

Group type: EXPERIMENTAL
Intervention: Losartan-based therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol-based regimen
Number of subjects: 0
Study: 14597940

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacemaker programmed to dual-chamber pacing
Number of subjects: 2010

Group type: COMPARATOR
Intervention: Dual-chamber pacemaker programmed to ventricular pacing
Number of subjects: 2010
Study: 10871094

Group type: EXPERIMENTAL
Intervention: 25% balsam of Peru in petrolatum applied for 3, 6, 24, 48, 72, and 96 hours
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Transparent foils with petrolatum test substance
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Serial doses printed on polyester squares
Number of subjects: 13
Study: 9339881

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR 75 mg once daily
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Venlafaxine IR 37.5 mg twice daily
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 278
Study: 8366227

Group type: EXPERIMENTAL
Intervention: PEEPe 35% of intrinsic PEEP (PEEPi)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PEEPe 58% of intrinsic PEEP (PEEPi)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PEEPe 86% of intrinsic PEEP (PEEPi)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no PEEPe)
Number of subjects: 9
Study: 3518765

Group type: EXPERIMENTAL
Intervention: Atracurium 0.6 mg kg‐1 (Group I, 20 patients)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atracurium 0.2 mg kg‐1 (Group II, 10 patients)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atracurium (both groups)
Number of subjects: 30
Study: 29970072

Group type: EXPERIMENTAL
Intervention: Arctostaphylos uva‐ursi (UU, bearberry extract arbutin) 105 mg, 3 times a day for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fosfomycin 3 g once
Number of subjects: 0
Study: 26474809

Group type: EXPERIMENTAL
Intervention: Family Nurse Partnership (FNP) plus usual care
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: Family Nurse Partnership (FNP)
Number of subjects: 1645

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1645
Study: 25917376

Group type: EXPERIMENTAL
Intervention: Monthly structured pharmaceutical care visits delivered by pharmacists for 6 months
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual diabetic care
Number of subjects: 68
Study: 24322383

Group type: EXPERIMENTAL
Intervention: darunavir/ritonavir
Number of subjects: 689

Group type: COMPARATOR
Intervention: lopinavir/ritonavir
Number of subjects: 689
Study: 20107144

Group type: EXPERIMENTAL
Intervention: Anthelmintic treatment at 0 and 3 months
Number of subjects: 591

Group type: COMPARATOR
Intervention: Iron-fortified biscuits providing an additional 20 mg iron/d as electrolytic iron 4 times/week
Number of subjects: 591

Group type: COMPARATOR
Intervention: IPT of malaria with sulfadoxine-pyrimethamine at 0 and 3 months
Number of subjects: 591
Study: 19175162

Group type: EXPERIMENTAL
Intervention: Q-factor guided LASIK
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional LASIK
Number of subjects: 84
Study: 15990345

Group type: EXPERIMENTAL
Intervention: Tidal breathing method with capsaicin 0.4 micromol/L
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dosimeter method with capsaicin 0.4 micromol/L
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 12946758

Group type: EXPERIMENTAL
Intervention: Vardenafil 5 mg
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Vardenafil 20 mg
Number of subjects: 580

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 580
Study: 11041173

Group type: EXPERIMENTAL
Intervention: Mitral valve replacement with preservation of subvalvular structure (MVRP)
Number of subjects: 68
Study: 8856838

Group type: EXPERIMENTAL
Intervention: Melatonin 1.0 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Melatonin 0.3 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1290313

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no pravastatin)
Number of subjects: 100
Study: 6235249

Group type: EXPERIMENTAL
Intervention: Etodolac 400 mg b.i.d.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Etodolac 600 mg b.i.d.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Ibuprofen 600 mg q.i.d.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Indomethacin 50 mg in the morning, 50 mg at noon, and 100 mg h.s.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Naproxen 375 mg b.i.d.
Number of subjects: 11
Study: 31489589

Group type: EXPERIMENTAL
Intervention: Apalutamide with ongoing ADT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29514163

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 2 mg/day for days 1-28 with regorafenib
Number of subjects: 0
Study: 26820395

Group type: EXPERIMENTAL
Intervention: Heracleum persicum hydroalcoholic fruit extract (300 mg/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 25634390

Group type: EXPERIMENTAL
Intervention: Nitroglycerin and lignocaine (3 ml solution) infiltrated subcutaneously at the site intended for puncture (Group NL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Saline and lignocaine infiltrated subcutaneously (Group SL)
Number of subjects: 200
Study: 22939439

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 481

Group type: COMPARATOR
Intervention: Control
Number of subjects: 481
Study: 20145564

Group type: COMPARATOR
Intervention: Nonstretching (NS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-volume PNF stretching (LVPNFS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-volume PNF stretching (HVPNFS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-volume static stretching (LVSS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-volume static stretching (HVSS)
Number of subjects: 15
Study: 18042603

Group type: EXPERIMENTAL
Intervention: Modified constraint-induced movement therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 32
Study: 16061897

Group type: EXPERIMENTAL
Intervention: Evaluator perspective
Number of subjects: 1253

Group type: COMPARATOR
Intervention: Social decision-maker perspective
Number of subjects: 1253
Study: 11838888

Group type: EXPERIMENTAL
Intervention: High-protein, low-fat diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-carbohydrate, low-fat diet
Number of subjects: 10
Study: 10422354

Group type: EXPERIMENTAL
Intervention: Holding therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 7768080

Group type: EXPERIMENTAL
Intervention: Felodipine (2.5 to 20 mg) once daily
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Felodipine (oral)
Number of subjects: 239
Study: 1416266

Group type: EXPERIMENTAL
Intervention: Budesonide nasal spray, 100 micrograms per nostril twice a day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 50
Study: 3998201

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg (single dose)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg (multiple doses, 200 mg every six hours and 400 mg before retiring)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Acetaminophen 750 mg (single dose alone)
Number of subjects: 4
Study: 30786924

Group type: EXPERIMENTAL
Intervention: Melanoma-associated antibodies (NY-ESO-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melanoma-associated antibodies (MelanA/MART1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melanoma-associated antibodies (gp100)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melanoma-associated antibodies (TRP1/TYRP1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melanoma-associated antibodies (TRP2/TYRP2)
Number of subjects: 0
Study: 29730186

Group type: EXPERIMENTAL
Intervention: High volume (HV, 350 mL) water load
Number of subjects: 19

Group type: COMPARATOR
Intervention: Low volume (LV, 50 mL) water load
Number of subjects: 19
Study: 26738952

Group type: EXPERIMENTAL
Intervention: Filtered Diesel Exhaust (DE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Unfiltered Diesel Exhaust (DE)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clean Air
Number of subjects: 26
Study: 24452238

Group type: EXPERIMENTAL
Intervention: High-flavonoid (HF) fruit and vegetables
Number of subjects: 174

Group type: COMPARATOR
Intervention: Increase in fruit and vegetables (regardless of flavonoid content)
Number of subjects: 174
Study: 22704052

Group type: EXPERIMENTAL
Intervention: Presence of easily visible seroma
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Presence of breast seroma
Number of subjects: 648
Study: 20304499

Group type: EXPERIMENTAL
Intervention: CF101 (1 mg, orally, twice daily for 12 weeks)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (matching vehicle-filled pills, orally, twice daily for 12 weeks)
Number of subjects: 68
Study: 19030213

Group type: EXPERIMENTAL
Intervention: GOS formula (0.24 g/100 mL)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 371

Group type: COMPARATOR
Intervention: Standard infant formula without GOS
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: GOS formula
Number of subjects: 371
Study: 15845693

Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg
Number of subjects: 40
Study: 11922254

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM) allograft
Number of subjects: 12

Group type: COMPARATOR
Intervention: Autogenous free gingival graft (FGG)
Number of subjects: 12
Study: 9611938

Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 7837002

Group type: EXPERIMENTAL
Intervention: Displays without noise points
Number of subjects: 0

Group type: COMPARATOR
Intervention: Displays with noise points
Number of subjects: 0
Study: 2964344

Group type: EXPERIMENTAL
Intervention: Erythromycin 2 percent gel
Number of subjects: 187

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 187
Study: 29203184

Group type: EXPERIMENTAL
Intervention: Modified transurethral enucleation and resection of the prostate (M‐TUERP)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional bipolar transurethral resection of the prostate (B‐TURP)
Number of subjects: 86
Study: 26433607

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS to the contralateral motor cortex
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo rTMS
Number of subjects: 20
Study: 25707524

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ketamine and Remifentanil
Number of subjects: 37
Study: 22407663

Group type: EXPERIMENTAL
Intervention: Kirtan Kriya meditation for 12 min per day for 8 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Listening to relaxation music for 12 min per day for 8 weeks
Number of subjects: 39
Study: 19923383

Group type: EXPERIMENTAL
Intervention: Low nonheme iron intake at baseline
Number of subjects: 2895

Group type: EXPERIMENTAL
Intervention: 3rd tertile of nonheme iron intake at baseline
Number of subjects: 2895

Group type: EXPERIMENTAL
Intervention: Heme iron intake
Number of subjects: 2895

Group type: EXPERIMENTAL
Intervention: Meat intake
Number of subjects: 2895

Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin and ferritin concentrations
Number of subjects: 2895
Study: 18227236

Group type: EXPERIMENTAL
Intervention: Subsidized coverage at $20 per month
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subsidized coverage at $100 per month
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study: 17136295

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prebiotics
Number of subjects: 0
Study: 15508781

Group type: EXPERIMENTAL
Intervention: Lumefantrine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 21